Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 1

Status

Completed 5

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5

Conditions

Uterine Cervical Neoplasms 4Condylomata Acuminata 3Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Papillomavirus Infections 1

Interventions

Paclitaxel 153Carboplatin 123Bevacizumab 87Cisplatin 66pembrolizumab 58Taxes 51Gemcitabine 51liposomal doxorubicin 39Topotecan 37olaparib 31Immunoglobulin G 27Disulfides 26Cyclophosphamide 24Brachytherapy 22Docetaxel 21human papillomavirus vaccine, L1 type 16, 18 20niraparib 19Platinum 19Nivolumab 18Magnetic Resonance Spectroscopy 181,2-diaminocyclohexaneplatinum II citrate 18rucaparib 17durvalumab 16Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 16Doxorubicin 16Radiotherapy, Intensity-Modulated 14Radiation 13Albumin-Bound Paclitaxel 13fludarabine phosphate 12fludarabine 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Has results × Vaccines, Synthetic × Gynecologic × Clear all
NCT00092534 2025-08-01

FUTURE II

Merck Sharp & Dohme LLC

Phase 3 Completed
12,167 enrolled 23 charts
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT03493542 2024-12-31

V501-213

Merck Sharp & Dohme LLC

Phase 3 Completed
766 enrolled 38 charts
Gynecologic

Uterine Cervical Dysplasia

NCT01245764 2018-11-14

GARDASILâ„¢ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)

Merck Sharp & Dohme LLC

Phase 3 Completed
250 enrolled 20 charts
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT00524745 2017-04-14

Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil

PATH

Phase NA Completed
903 enrolled 10 charts
Gynecologic

Uterine Cervical Neoplasms

NCT00092495 2015-01-13

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

Merck Sharp & Dohme LLC

Phase 3 Completed
3,055 enrolled 25 charts
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon âš¡